To access this element change to forms mode OFF
Grant Award View - GA30245
Targeting nucleolar DNA damage response as a novel therapeutic strategy...
GA ID:
GA30245
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2022
Value (AUD):
$900,028.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
Targeting nucleolar DNA damage response as a novel therapeutic strategy for high grade serous ovarian cancer
Purpose:
New therapies are required to improve outcomes for patients with ovarian cancer. In this proposal, we will optimise and validate the effectiveness of a new class of drugs we have discovered and developed to selectively damage the DNA of cancer cells, resulting in death of the cancers while sparing normal tissue.
GO ID:
GO Title:
NHMRC Project Grant Scheme
Internal Reference ID:
GNT1162052
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA